Close

Merck (MRK) strengthens growth narrative, Bristol-Myers Squibb (BMY) 'difficult to own' - BMO Capital Oct 27, 2023 10:54AM
BMO Capital Upgrades Merck (MRK) to Outperform Oct 27, 2023 04:06AM
Mirati Therapeutics (MRTX) seen worth more than double in a buyout Nov 23, 2022 12:40PM
Merck to buy Imago for $1.35 billion to broaden portfolio of blood disorder drugs Nov 21, 2022 06:53AM
Merck lifts full-year forecast as Keytruda sales soar Oct 27, 2022 06:35AM
View Older Stories

Apr 5, 2022 02:36PM BMO Capital Reiterates Outperform Rating on Merck (MRK), but Awaits "More Concrete Data" on Cardiovascular Programs
Feb 3, 2022 07:46AM BMO Capital Reiterates Market Perform Rating on Merck (MRK) Following Earnings
Nov 18, 2021 04:22PM BMO Capital Starts Merck (MRK) at Market Perform
May 1, 2019 07:50AM Merck (MRK) PT Raised to $84 at BMO Capital
Feb 19, 2019 08:57AM Merck (MRK) PT Raised to $83 At BMO On Keytruda Market Opportunity
Jan 23, 2019 02:46AM BMO Capital Downgrades Merck (MRK) to Market Perform
Oct 26, 2018 08:37AM Merck (MRK) PT Lowered to $80 at BMO Capital
Oct 22, 2018 04:15AM Merck (MRK) PT Raised to $82 at BMO Capital
May 17, 2018 02:03PM Dr. Roger Dansey Departure at Merck (MRK) an 'Incrementally Negative' - BMO
Apr 26, 2018 02:31AM Merck (MRK) PT Raised to $70 at BMO Capital
Apr 9, 2018 09:48AM Merck's Keytruda helps lung cancer patients live longer in trial
Apr 6, 2018 09:51AM ECHO-301 Not a Key Driver for Merck (MRK) - BMO
Feb 6, 2018 06:51AM Bristol-Myers Squibb Co. (BMY) PT Lowered to $51 at BMO Capital; 'IO NSCLC Complexity Increases'
Jan 30, 2018 03:01PM AbbVie (ABBV), Eli Lilly (LLY) More Vulnerable Than Other Drug Cos. on Amazon Entry - BMO
Jan 17, 2018 05:39AM Merck (MRK) PT Raised to $72 at BMO Capital
Jan 16, 2018 12:53PM Merck (MRK) Surges as it May Have Made Chemo Alone Obsolete in First-Line Treatment for Non-Small Cell Lung Cancer
Oct 30, 2017 01:13PM Merck (MRK) Defended at BMO Capital
Jul 24, 2017 09:11AM Merck (MRK) PT Lowered to $73 at BMO Capital Ahead of 2Q Announcement on 7/28 BMO; '2Q Should be In-Line'
Jun 6, 2017 06:18AM Merck (MRK): ASCO Data Increases Confidence in LT Story - BMO
May 11, 2017 06:43AM Merck (MRK) PT Raised to $74 at BMO Capital; Keytruda 1L-Lung Approval a 'Meaningful Positive'
Apr 21, 2017 06:36AM Merck (MRK): Expecting a Miss - BMO
Feb 15, 2017 05:55AM Merck (MRK) PT Lowered to $70 at BMO Capital on EPOCH Stoppage
Jan 25, 2017 06:24AM Merck (MRK): Expecting Guidance Downside, Cutting PT - BMO
Jan 17, 2017 10:29AM AstraZeneca (AZN) MYSTIC Change Positive for Merck (MRK), Less so for Bristol-Myers Squibb (BMY) - BMO
Nov 9, 2016 12:03PM Complete Donald Trump Stock Impact Guide
Nov 9, 2016 07:54AM Major Pharma Got a Major Win Last Night - BMO
Oct 10, 2016 09:17AM Pre-Open Stock Movers 10/10: (IPCI) (TSRO) (MYL) Higher; (TWTR) (BMY) (DOV) Lower (more...)
Aug 5, 2016 12:25PM BMO Capital Upgrades Merck (MRK) to Outperform, $72 PT
Aug 5, 2016 10:00AM Bristol-Myers (BMY) Opdivo Trial Miss a 'Seismic Event', BMO Capital Says (MRK)
Aug 1, 2016 09:01AM Merck (MRK): Good But Not Enough - BMO
Jul 18, 2016 06:17AM BMO Capital Downgrades Merck (MRK) to Market Perform
Jun 28, 2016 07:02AM Merck (MRK): Management Meeting Reinforced Bullish Views - BMO
May 5, 2016 12:19PM Could Merck (MRK) Join the Bidding for Medivation (MDVN)?
Apr 18, 2016 12:24PM Latest Data from EASL Shows Gilead (GILD) Continues to Dominate Hep-C Market - BMO Capital
Jan 29, 2016 07:27AM BMO Capital Cuts Price Target on Merck (MRK) Following FDA's Zepatier Approval
Jan 12, 2016 01:46PM Bristol-Myers (BMY) JP Morgan Update 'Incrementally Positive', Negative for Merck (MRK) - BMO Capital
Sep 16, 2015 02:53PM BMO Incrementally More Positive on Merck (MRK) as Omarigliptin Met Primary Endpoint in Phase 3
Aug 13, 2015 06:32AM BMO Capital Upgrades Merck (MRK) to Outperform
May 8, 2014 10:42AM Notable Analyst Rating Changes 05/08: (SCTY) (YELP) (FOSL) Upgraded; (MRK) (AGN) (PENN) Downgraded
May 8, 2014 06:49AM BMO Capital Downgrades Merck (MRK) to Market Perform
May 7, 2014 11:07AM Notable Analyst Rating Changes 05/07: (JCP) (ABBY) (FE) Upgraded; (WFM) (GNC) (GRPN) Downgraded
Nov 1, 2013 10:47AM BMO Capital Upgrades Merck (MRK) to Outperform
Jul 18, 2013 10:50AM Notable Analyst Rating Changes 07/18: (EXC) (LNC) (XLNX) Upgraded; (NTRS) (TLM) (MRK) Downgraded
Jul 18, 2013 07:17AM BMO Capital Downgrades Merck (MRK) to Market Perform
May 28, 2013 10:55AM Notable Analyst Rating Changes 05/28: (GSK) (KSU) (MRK) Upgraded; (STJ) (FE) (VSAT) Downgraded
Nov 12, 2012 07:27AM BMO Capital Upgrades Merck (MRK) to Outperform
May 18, 2012 08:11AM BMO Capital Starts Merck (MRK) at Outperform
Mar 19, 2012 11:38AM BMO Cuts Cardiome Pharma (CRME) to Market Perform Amid Vernakalant News
Jul 21, 2009 09:29AM David Moenning's Daily State of the Markets: 7/21
Mar 13, 2009 10:16AM David Moenning's Daily State of the Markets: 3/13
View Older Stories